Alvotech Strikes $45m Deal With Yas Holding

Biosimilars Deal Includes 2.5% Stake And MENA Rights

 
• By David Wallace
Syringe
The deal gives Alvotech another injection of cash following Fuji Pharma’s $50m investment announced last year • Source: Shutterstock

More from Deals

More from Business